00:20 , Jun 7, 2011 |  BC Extra  |  Financial News

Endo raises $900M in note deal

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) raised $900 million in a bumped-up offering of senior unsecured notes. The offering comprises $500 million in 7% notes due 2019 and $400 million in 7.25% notes due 2022. Last...
07:00 , May 30, 2011 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Amgen Inc. (NASDAQ:AMGN) lost $1.51 to $59.35 on a newsy week. Partner Johnson & Johnson (NYSE:JNJ) said FDA lifted a clinical hold on a Phase II trial of fulranumab to treat cancer pain. The pharma...
00:32 , May 27, 2011 |  BC Extra  |  Financial News

Endo planning $700M note deal

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) plans to sell $700 million in senior unsecured notes. The biotech plans to use a portion of the proceeds to fund its previously announced acquisition of pelvic health company American...
07:00 , Apr 18, 2011 |  BC Week In Review  |  Company News

American Medical Systems Holdings Inc., Endo deal

Endo will acquire pelvic health company American Medical for $30 per share, or about $2.9 billion in cash, including the repayment of $312 million of American Medical's debt. The price is a 34% premium to...
07:00 , Apr 18, 2011 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) gained $1.83 (16%) to $13.09 on Friday after EMA's CHMP recommended approval of Bydureon exenatide once weekly to treat Type II diabetes. Amylin and Eli Lilly and Co. (NYSE:LLY) co-developed Bydureon,...
00:28 , Apr 12, 2011 |  BC Extra  |  Company News

Endo to acquire American Medical Systems

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) will acquire pelvic health company American Medical Systems Holdings Inc. (NASDAQ:AMMD) for $30 per share, or about $2.9 billion, including the repayment of $312 million of American Medical's debt. The...
07:00 , Oct 12, 2009 |  BC Week In Review  |  Company News

American Medical Systems Holdings, Conceptus deal

Women's health company Conceptus acquired from American Medical full rights to the Essure birth control system through the purchase of all patents and IP associated with Ovion Inc. for $23.6 million in cash. Conceptus previously...